Erik Hertervig

Medicin och livsvetenskap

1. Sphingomyelin Phosphodiesterase 100%
2. Ulcerative Colitis 65%
3. Infliximab 55%
4. Sphingomyelins 42%
5. Colectomy 28%
6. Inflammatory Bowel Diseases 23%
7. Ileostomy 20%
8. Collagenous Colitis 20%
9. Crohn Disease 19%
10. Type 7 Cyclic Nucleotide Phosphodiesterases 16%
11. Steroids 15%
12. Adenoma 15%
13. Milk 15%
14. Knockout Mice 14%
15. CT-P13 14%
16. Placebos 14%
17. nucleotide pyrophosphatase 13%
18. vedolizumab 13%
19. Microscopic Colitis 12%
20. Carcinogenesis 12%
21. thiopurine methyltransferase 12%
22. Colitis 12%
23. Bile 12%
24. Azoxymethane 11%
25. Therapeutics 11%
26. Biosimilar Pharmaceuticals 11%
27. Enterocolitis 11%
28. Budesonide 10%
29. Adalimumab 10%
30. Antineutrophil Cytoplasmic Antibodies 10%
31. Ceramides 10%
32. Colorectal Neoplasms 10%
33. Adenomatous Polyposis Coli 10%
34. Sphingolipids 9%
35. Cyclosporine 9%
36. Human Activities 9%
37. Colon 9%
38. Biological Therapy 9%
39. Endoscopic Retrograde Cholangiopancreatography 9%
40. Selenium 9%
41. Hep G2 Cells 8%
42. Glutathione Transferase 8%
43. Enzymes 8%
44. Intestinal Mucosa 8%
45. Polyps 8%
46. Meals 8%
47. Cell Proliferation 7%
48. Immunologic Factors 7%
49. Platelet Activating Factor 7%
50. Observational Studies 7%